| |
 |
Joseph David Santangelo Patents |
|
Inventor: Santangelo; Joseph David
Address: Berkshire, GB
No. of patents: 6
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7419672 |
Genes and proteins, and their use |
September 2, 2008 |
| According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines t |
| 7217415 |
NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use |
May 15, 2007 |
| According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be located on the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines for the |
| 7211264 |
Attenuated microorganisms for the treatment of infection |
May 1, 2007 |
| The present invention pertains to a Salmonella microorganism having an attenuating mutation which disrupts the expression of a gene located within the Spi2 pathogenicity island, and an auxotrophic mutation. The microorganism therefore has a double mutation which helps prevent reactiv |
| 6890539 |
Genes and proteins, and their use |
May 10, 2005 |
| A protein from Group B Streptococcus is shown to be an outer surface protein and is a useful target for antimicrobial therapy. |
| 6812021 |
Genes and proteins and their use |
November 2, 2004 |
| According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vacaccines to |
| 6756042 |
Attenuated microorganisms for the treatment of infection |
June 29, 2004 |
| The present invention pertains to a Salmonella microorganism having an attenuating mutation which disrupts the expression of a gene located within the Spi2 pathogenicity island, and an auxotrophic mutation. The microorganism therefore has a double mutation which helps prevent reactiv |
|
|
|
